Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Completed · Phase 2/Phase 3

Conditions studied: Stroke, Myocardial Infarctions

In brief

The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.

Key facts

Study ID

NCT01586975

Run by

Northwestern University

People needed

93

Starts

2007-07-01

Expected to finish

2011-12-01

Last updated by the study team

2015-12-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must be taking Aspirin or Plavix
• Patient must have had a stroke, TIA or cerebrovascular disease

You may not qualify if…

• None

Where it is running

• Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.